Evaluasi  Efektivitas Penggunaan Telehealth  dalam Meningkatkan Kemampuan Perawatan diri  dan Kontrol Glikemik pada Pasien Diabetes Mellitus : Narrative Review

Article Sidebar

PDF
Published: 30-10-2025
DOI: https://doi.org/10.65258/jutekom.v1.i4.21
Keywords:
diabetes mellitus, self care management, glicemic control, telehealth

Main Article Content

fakhriatul falah
Poltekkes Kemenkes Gorontalo

Abstract

Diabetes is a disease characterized by elevated blood glucose levels, known as hyperglycemia. Poor self-care skills in diabetes patients result in uncontrolled blood sugar and various complications. To address this, educational and counseling strategies are implemented for both diabetes patients and their families through telehealth. The purpose of this study was to evaluate the effectiveness of using various telehealth media in improving self-care behavior and glycemic control in diabetes patients. This study was conducted using a literature review method using a comparative experimental design through a randomized controlled trial method. Based on a systematic analysis of 18 articles, it was found that telemedicine can be used as an effective educational medium to improve self-care skills in diabetes patients and improve glycemic control in patients by reducing blood glucose and HbA1C levels.

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 1 No. 4 (2025): Oktober 2025

Section

Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

How to Cite

Evaluasi  Efektivitas Penggunaan Telehealth  dalam Meningkatkan Kemampuan Perawatan diri  dan Kontrol Glikemik pada Pasien Diabetes Mellitus : Narrative Review (fakhriatul falah , Trans.). (2025). Jurnal Teknologi Informasi Dan Ilmu Komputer, 1(4), 158-163. https://doi.org/10.65258/jutekom.v1.i4.21

References

[1] F. F. Fakhriatul, S. Syamsidar, and M. A. K. Mira, “Upaya Peningkatan Self Care Management Melalui Pendekatan Peer Group Support Pada Pasien Diabetes Mellitus,” Bina Generasi : Jurnal Kesehatan, vol. 14, no. 1, pp. 71–78, 2022, doi: 10.35907/bgjk.v14i1.249.

[2] [M. I. Choliq, “Efektivitas Aplikasi Telemedicine sebagai Self Care Management dan Kepatuhan Minum Obat Pada Pasien DM Tipe 2,” Universitas Panji Sakti, Buleleng, 2023.

[3] J. Penelitian et al., “Implementasi Telehealth pada pasien Diabetes melitus saat pandemi Covid-19: Tinjauan sistematis,” NURSCOPE: Jurnal Penelitian dan Pemikiran Ilmiah Keperawatan, vol. 7, no. 1, pp. 53–60, Jun. 2021, doi: 10.30659/nurscope.7.1.45-52.

[4] E. FITRIA, “PENGARUH APLIKASI TELEMEDICINE DALAM MENINGKATKAN KUALITAS HIDUP PASIEN DIABETES MELITUS,” Universitas PGRI Adi Buana , Surabaya, 2023. Accessed: Aug. 19, 2025. [Online]. Available: http://repository.unipasby.ac.id/

[5] C. Y. Han et al., “Telemedicine-assisted structured self-monitoring of blood glucose in management of T2DM results of a randomized clinical trial,” BMC Med Inform Decis Mak, vol. 23, no. 1, pp. 1–8, Dec. 2023, doi: 10.1186/S12911-023-02283-4/TABLES/3.

[6] F. Boscari, S. Ferretto, A. Uliana, A. Avogaro, and D. Bruttomesso, “Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown,” Nutr Diabetes, vol. 11, no. 1, Jun. 2021, doi: 10.1038/S41387-020-00147-8.

[7] L. Yang et al., “Effects of Mobile Phone–Based Telemedicine Management in Patients With Type 2 Diabetes Mellitus: A Randomized Clinical Trial,” American Journal of the Medical Sciences, vol. 363, no. 3, pp. 224–231, Mar. 2022, doi: 10.1016/j.amjms.2021.09.001.

[8] W. Yin, Y. Liu, H. Hu, J. Sun, Y. Liu, and Z. Wang, “Telemedicine management of type 2 diabetes mellitus in obese and overweight young and middle-aged patients during COVID-19 outbreak: A single-center, prospective, randomized control study,” PLoS One, vol. 17, no. 9, p. e0275251, Sep. 2022, doi: 10.1371/JOURNAL.PONE.0275251.

[9] A. U. Onyia, G. Berhie, A. Cecchetti, and A. Hines, “The Use of Digital Telehealth for the Self-Management of Type 2 Diabetes Patients in Hinds County, Mississippi: A Pilot Study,” J Patient Exp, vol. 10, Jan. 2023, doi: 10.1177/23743735231188835.

[10] M. J. Crowley et al., “Effect of a Comprehensive Telehealth Intervention vs Telemonitoring and Care Coordination in Patients With Persistently Poor Type 2 Diabetes Control: A Randomized Clinical Trial,” JAMA Intern Med, vol. 182, no. 9, pp. 943–952, Sep. 2022, doi: 10.1001/JAMAINTERNMED.2022.2947.

[11] D. W. Franco et al., “The impact of a telehealth intervention on the metabolic profile of diabetes mellitus patients during the COVID-19 pandemic - A randomized clinical trial,” Prim Care Diabetes, vol. 16, no. 6, pp. 745–752, Dec. 2022, doi: 10.1016/j.pcd.2022.09.011.

[12] F. Calikoglu et al., “Telemedicine as a Motivational Tool to Optimize Metabolic Control in Patients with Diabetes in Turkey: A Prospective, Randomized, Controlled TeleDiab Trial,” https://home.liebertpub.com/tmj, vol. 29, no. 4, pp. 518–530, Apr. 2023, doi: 10.1089/TMJ.2022.0028.

[13] S. Di Molfetta et al., “A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial,” Journal of Endocrinological Investigation 2022 45:9, vol. 45, no. 9, pp. 1663–1671, Apr. 2022, doi: 10.1007/S40618-022-01802-W.

[14] L. Siminerio et al., “Examining a Diabetes Self-Management Education and Support Telemedicine Model With High-Risk Patients in a Rural Community,” J Diabetes Sci Technol, vol. 17, no. 5, pp. 1190–1197, Sep. 2023, doi: 10.1177/19322968231180884/ASSET/AC792681-A0EA-4056-BD42-3F813AE1AF9C/ASSETS/IMAGES/LARGE/10.1177_19322968231180884-FIG1.JPG.

[15] A. Munda, Z. Mlinaric, P. A. Jakin, M. Lunder, and D. Pongrac Barlovic, “Effectiveness of a comprehensive telemedicine intervention replacing standard care in gestational diabetes: a randomized controlled trial,” Acta Diabetol, vol. 60, no. 8, pp. 1037–1044, Aug. 2023, doi: 10.1007/S00592-023-02099-8/METRICS.

[16] E. M. Vaughan, D. J. Hyman, A. D. Naik, S. L. Samson, J. Razjouyan, and J. P. Foreyt, “A Telehealth-supported, Integrated care with CHWs, and MEdication-access (TIME) Program for Diabetes Improves HbA1c: a Randomized Clinical Trial,” J Gen Intern Med, vol. 36, no. 2, pp. 455–463, Feb. 2021, doi: 10.1007/S11606-020-06017-4/TABLES/3.

[17] S. Ballesta et al., “Telehealth model versus in-person standard care for persons with type 1 diabetes treated with multiple daily injections: an open-label randomized controlled trial,” Front Endocrinol (Lausanne), vol. 14, p. 1176765, Jun. 2023, doi: 10.3389/FENDO.2023.1176765/BIBTEX.

[18] H. Buysse, P. Coremans, F. Pouwer, and J. Ruige, “Sustainable improvement of HbA1c and satisfaction with diabetes care after adding telemedicine in patients on adaptable insulin regimens: Results of the TeleDiabetes randomized controlled trial,” Health Informatics J, vol. 26, no. 1, pp. 628–641, Mar. 2020, doi: 10.1177/1460458219844369/SUPPL_FILE/SUPPLEMENTARY_FILE.PDF.

[19] R. L. Gal et al., “Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose Monitoring,” J Endocr Soc, vol. 4, no. 9, Sep. 2020, doi: 10.1210/JENDSO/BVAA076.

[20] V. A. Raafi, S. Saryono, and Y. Sari, “Implementasi Telehealth pada pasien Diabetes melitus saat pandemi Covid-19: Tinjauan sistematis,” NURSCOPE: Jurnal Penelitian Dan Pemikiran Ilmiah Keperawatan, vol. 7, no. 1, pp. 53–60, 2021.